Uncovering the hidden universe of metabolite-specific T lymphocytes,using human multiorgan microphysiological systems.

利用人体多器官微生理系统揭示代谢物特异性 T 淋巴细胞的隐藏宇宙。

基本信息

  • 批准号:
    10795165
  • 负责人:
  • 金额:
    $ 22.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-07-01 至 2027-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Metabolic and inflammatory disorders such as autoimmune and neurodegenerative diseases are increasing at alarming rates. Many of these are not tissue-specific occurrences but complex and often overlapping pathologies of unknown origin for which no cure exists. Examples are concurring pathologies of the gut-liver axis, such as inflammatory bowel disease and inflammatory pathologies of the liver. The discovery of “unconventional” T lymphocytes and their ability to respond to non-peptide antigens, marks a new area in the exploration of how migratory cells and immunometabolic networks shape the emergence of autoimmune and metabolic diseases. These are comprised of a heterogeneous group of lymphocytes, such as mucosa-associated invariant T cells, whose invariant TCR can recognize cellular and microbial metabolites via presentation through the MHC-like receptor 1 (MR1). Emerging evidence suggest MR1-restricted T cells to be implicated in a wide variety of disorders ranging from ulcerative colitis to type 1 diabetes, autoimmune hepatitis and multiple sclerosis via TCR- specific and non-specific means. However, lack of models relevant to human physiology represents a significant hurdle in our understanding of how MR1-restricted T cells affect the host and diseases. We have developed an approach that utilizes multiorgan human microphysiological models (MOMPS) of donor-matched tissues and unbiased systems biology tools to gain granular insight into causal relationships between cellular crosstalk and immunometabolic illnesses. In order to gain critical knowledge about the heterogeneity and functionality of MR1-restricted lymphocytes, we will combine single-cell characterization of human MR1-restricted T cells across donor-matched tissues and circulation, with mechanistic studies in a microphysiological model of the gut-liver axis. These MOMPS will be used to systematically search for causal relationships between MR1-restricted lymphocytes, tissues, and external factors by reconstructing donor tissue at various levels of complexity. Each level will be challenged via predetermined inflammatory and metabolic perturbations. Multiomic observation of changes based on interaction and perturbation at each degree of complexity will allow us to construct interaction networks that reveal causal relationships among entities. With computational tools and resolution into molecular underpinnings of cellular and tissue homeostasis, MOMPS represent a unique opportunity to systematically dissect how interactions at a lower order inform new behavior at the macro scale within and between organ systems. While the gut-liver axis will serve as a model in this proposal, the developed approach, together with fundamental biological insights into MR1 expression by parenchymal tissue and function of MR1-restricted T cells, will be applicable to other organ systems and a variety of pathologies. Our overarching goal is to identify tangible targets and new cell-based approaches to modulate autoimmune pathologies but also contribute new tools that shed light on the fundamental origins of complex diseases
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin Trapecar其他文献

Martin Trapecar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martin Trapecar', 18)}}的其他基金

Uncovering the hidden universe of metabolite-specific T lymphocytes,using human multiorgan microphysiological systems.
利用人体多器官微生理系统揭示代谢物特异性 T 淋巴细胞的隐藏宇宙。
  • 批准号:
    10652631
  • 财政年份:
    2022
  • 资助金额:
    $ 22.89万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Operating Grants
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Small Business Research Initiative
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 22.89万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了